<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="SymbolMT" color="#000000"/>
	<fontspec id="font6" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font7" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font8" size="9" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font9" size="10" family="GillSans" color="#ffffff"/>
	<fontspec id="font10" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font11" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font12" size="10" family="GillSans,Italic" color="#000000"/>
<text top="41" left="55" width="118" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>Clinical and Molecular Allergy</i></text>
<text top="41" left="173" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2006, </text>
<text top="41" left="200" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>4</b></text>
<text top="41" left="205" width="7" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:6</text>
<text top="41" left="343" width="211" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.clinicalmolecularallergy.com/content/4/1/6</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t6" reading_order_no="65" segment_no="15" tag_type="text">Page 3 of 6</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="66" segment_no="16" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="439" left="55" width="213" height="9" font="font4" id="p1_t8" reading_order_no="16" segment_no="4" tag_type="text">healthy individuals no detectable amounts of TNF-</text>
<text top="436" left="268" width="6" height="12" font="font5" id="p1_t9" reading_order_no="17" segment_no="4" tag_type="text">Î±</text>
<text top="439" left="274" width="22" height="9" font="font4" id="p1_t10" reading_order_no="18" segment_no="4" tag_type="text"> were</text>
<text top="451" left="55" width="40" height="9" font="font4" id="p1_t11" reading_order_no="19" segment_no="4" tag_type="text">observed.</text>
<text top="475" left="55" width="64" height="9" font="font6" id="p1_t12" reading_order_no="20" segment_no="8" tag_type="title"><i><b>Flow cytometry</b></i></text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="21" segment_no="9" tag_type="text">Surface markers were detected using primary labeled anti-</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="22" segment_no="9" tag_type="text">bodies: CCR3-FITC, CCR5-FITC, CCR8-FITC, CXCR3-</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="23" segment_no="9" tag_type="text">FITC (R&amp;Dsystems, Abingdon, UK), CD4-PE-Cy5 and</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="24" segment_no="9" tag_type="text">CD45RO-PE (Dakocytomation, Glostrup, Denmark).</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="25" segment_no="9" tag_type="text">Three-color flow cytometry was performed on day 0 and</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="26" segment_no="9" tag_type="text">day 7 on a FACScan (Becton Dickinson, Heidelberg, Ger-</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="27" segment_no="9" tag_type="text">many) using WinList (Verity Software House, Topsham,</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="28" segment_no="9" tag_type="text">USA) software for analysis. Isotype control cut-off values</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="29" segment_no="9" tag_type="text">were set to &gt; 98% and 10.000 PBMC were acquired. Gat-</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="30" segment_no="9" tag_type="text">ing was done by firstly applying a CD4+ gate followed by</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="31" segment_no="9" tag_type="text">determination of the percentage and mean fluorescence</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="32" segment_no="9" tag_type="text">intensity (MFI) of the CD45RO and chemokine receptor</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="33" segment_no="9" tag_type="text">double positive population. CD45RO is a marker of effec-</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="34" segment_no="9" tag_type="text">tor and memory T cells, however throughout this article</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="35" segment_no="9" tag_type="text">these CD4+ CD45RO+ T cells will be mentioned as mem-</text>
<text top="662" left="55" width="143" height="9" font="font4" id="p1_t28" reading_order_no="36" segment_no="9" tag_type="text">ory T helper cells for convenience.</text>
<text top="686" left="55" width="76" height="9" font="font6" id="p1_t29" reading_order_no="37" segment_no="13" tag_type="title"><i><b>Statistical analysis</b></i></text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="38" segment_no="14" tag_type="text">Samples were compared using non-parametric statistics</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="39" segment_no="14" tag_type="text">(Kruskall-Wallis test or Wilcoxon's test for matched pairs).</text>
<text top="721" left="55" width="195" height="9" font="font4" id="p1_t32" reading_order_no="40" segment_no="14" tag_type="text">Values of P &lt; 0.05 were considered significant.</text>
<text top="439" left="313" width="36" height="10" font="font7" id="p1_t33" reading_order_no="41" segment_no="5" tag_type="title"><b>Results</b></text>
<text top="451" left="313" width="25" height="9" font="font6" id="p1_t34" reading_order_no="42" segment_no="6" tag_type="title"><i><b>Day 0</b></i></text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t35" reading_order_no="43" segment_no="7" tag_type="text">Immediate after isolation of the PBMCs, the cells were</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t36" reading_order_no="44" segment_no="7" tag_type="text">subjected to flow cytometric analysis. No significant dif-</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t37" reading_order_no="45" segment_no="7" tag_type="text">ferences in the percentage of CCR3+, CCR5+, CCR8+ and</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t38" reading_order_no="46" segment_no="7" tag_type="text">CXCR3+ memory Th cells from allergic, asymptomatically</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t39" reading_order_no="47" segment_no="7" tag_type="text">sensitized and healthy individuals were observed (Figure</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t40" reading_order_no="48" segment_no="7" tag_type="text"><a href="">1). </a>Likewise, no differences in MFI were observed between</text>
<text top="533" left="313" width="184" height="9" font="font4" id="p1_t41" reading_order_no="49" segment_no="7" tag_type="text">the three donor groups (results not shown).</text>
<text top="557" left="313" width="25" height="9" font="font6" id="p1_t42" reading_order_no="50" segment_no="10" tag_type="title"><i><b>Day 7</b></i></text>
<text top="569" left="313" width="71" height="9" font="font8" id="p1_t43" reading_order_no="51" segment_no="11" tag_type="title"><i>Effect of stimulation</i></text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t44" reading_order_no="52" segment_no="12" tag_type="text">No significant differences in chemokine receptors (neither</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t45" reading_order_no="53" segment_no="12" tag_type="text">expressed as the percentage of positive cells nor as MFI)</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t46" reading_order_no="54" segment_no="12" tag_type="text">were observed between day 0 and the cells having been</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t47" reading_order_no="55" segment_no="12" tag_type="text">kept in antigen-free medium for 7 days as controls. Thus</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t48" reading_order_no="56" segment_no="12" tag_type="text">the medium alone and the experimental set-up did not</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="57" segment_no="12" tag_type="text">influence the chemokine receptor expression. After TTx</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="58" segment_no="12" tag_type="text">stimulation a significant increase in MFI was observed for</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="59" segment_no="12" tag_type="text">CCR3 in the allergic and asymptomatically sensitized</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="60" segment_no="12" tag_type="text">individuals, but not in the healthy control group (Table</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t53" reading_order_no="61" segment_no="12" tag_type="text"><a href="">2). </a>However, no increases in the percentage of CCR3+</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t54" reading_order_no="62" segment_no="12" tag_type="text">memory Th cells were observed in any of the groups.</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t55" reading_order_no="63" segment_no="12" tag_type="text">CCR5 increased both as MFI and the percentage of CCR5+</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="64" segment_no="12" tag_type="text">memory Th cells in the asymptomatically sensitized and</text>
<text top="334" left="55" width="275" height="9" font="font9" id="p1_t57" reading_order_no="6" segment_no="2" tag_type="title">Percentage chemokine receptor positive memory T helper cells day 0</text>
<text top="334" left="55" width="37" height="9" font="font10" id="p1_t58" reading_order_no="5" segment_no="2" tag_type="title"><b>Figure 1</b></text>
<text top="345" left="55" width="317" height="9" font="font10" id="p1_t59" reading_order_no="7" segment_no="3" tag_type="text"><b>Percentage chemokine receptor positive memory T helper cells day 0</b></text>
<text top="345" left="372" width="171" height="9" font="font11" id="p1_t60" reading_order_no="8" segment_no="3" tag_type="text">. Percentage CCR3+, CCR5+, CCR8+ and </text>
<text top="356" left="55" width="499" height="9" font="font11" id="p1_t61" reading_order_no="9" segment_no="3" tag_type="text">CXCR3+ memory Th cells from allergic (dots), asymptomatically sensitized (triangles) and healthy control (crosses) individuals </text>
<text top="366" left="55" width="80" height="9" font="font11" id="p1_t62" reading_order_no="10" segment_no="3" tag_type="text">on day 0 immediate </text>
<text top="366" left="135" width="25" height="9" font="font12" id="p1_t63" reading_order_no="11" segment_no="3" tag_type="text"><i>ex vivo</i></text>
<text top="366" left="160" width="394" height="9" font="font11" id="p1_t64" reading_order_no="12" segment_no="3" tag_type="text">. - = median value. n = 10 for the healthy controls, n = 10 for the asymptomatically sensitized and n </text>
<text top="377" left="55" width="499" height="9" font="font11" id="p1_t65" reading_order_no="13" segment_no="3" tag_type="text">= 8 for the allergic individuals except for CCR8 where n = 6 for the asymptomatically sensitized and allergic individuals. 10.000 </text>
<text top="388" left="55" width="496" height="9" font="font11" id="p1_t66" reading_order_no="14" segment_no="3" tag_type="text">PBMCs were acquired for the analysis. Isotype control cut-off values were set to &gt;98%. Samples were run in monocates. For </text>
<text top="398" left="55" width="183" height="9" font="font11" id="p1_t67" reading_order_no="15" segment_no="3" tag_type="text">experimental design and analysis see Methods.</text>
</page>
</pdf2xml>
